1. Most Discussed
  2. Gainers & Losers
PBT 4.5¢

Prana Biotechnology Limited (ADR) Receives Average Target Price of $3

  1. interestingtome

    1,847 Posts.
    Mathew Donald · Feb 4th, 2015 · 0 Comment

    Prana Biotechnology Limited (ADR) (NASDAQ:pRAN) shares are expected to touch $3 in the short term. This short term price target has been shared by 1 analysts. However, the standard deviation of short term price estimate has been valued at 0. The target price could hit $3 on the higher end and $3 on the lower end.The information is based on average recommendation on company rating and price target for short term (6 to 12 months) .

    Prana Biotechnology Limited (ADR) (NASDAQ:pRAN) : Strong bullish mood helped the shares of Prana Biotechnology Limited (ADR) (NASDAQ:pRAN) appreciate in value. The share price gained 0.14 points or 9.33% to close at $1.64 with 391,313 shares exchanging hands. The trading began on a bullish sentiment but no considerable downsides were seen throughout the day; the intraday low was registered at $1.51. However, the shares hit an intraday high of $1.65. The previous close of the share price was $1.5. Prana Biotechnology Limited (ADR) (NASDAQ:pRAN) has a market cap of $80 million and the number of outstanding shares is calculated to be 48,894,000. The 52-week low of the share price is $1.36.

    Prana Biotechnology Limited (ADR) (NASDAQ:pRAN) has a short ratio of 10.62 , which means that the counter should take 10.62 days to cover the total short interest. A high short ratio indicates a high build-up of short positions in the counter whereas a low short ratio implies that there are fewer short positions. The average daily volume for the last 20 days is 190,730 shares. The volume traded during the last 20 days is 0.39% of the total outstanding shares. The 1-month %change in short interest is -9.05%.The shares have witnessed a change of -20.4% in short interest in the past 3 months. The total monthly shares shorted are 0.047 times the total common shares outstanding.
    Prana Biotechnology Limited (Prana) is development stage company. The Company is engaged in develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimers disease. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company is also focusing on Huntingtons and Parkinsons diseases. Other potential applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease and age-related cataracts.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.